GlobeNewsWire
10 Oct 2025, 13:20 UTC · 48w ago
Verdict
Headline takes no side. We score NIVF +0.60 across two claims — strongly bullish.
+0.60strongly bullish
More positive than 76% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Zacks Small-Cap Research has initiated equity research coverage on NewGenIvf Group Limited (NIVF).
More positive than 65% of claims this week
NewGenIvf Group has executed a Share Purchase Agreement to acquire an initial 2% equity interest in K25.ai, with the option to increase this to 10%.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 54% of claims this week
Which stocks this story touches
More positive than 76% of ticker scores this week
The company is receiving new equity research coverage from Zacks and expanding its portfolio through strategic acquisitions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Benzinga
1h ago
−99.9%
Price is moving against the score
$0.7755 vs $1031.40 close before publication (Oct 9) · not market-adjusted
NIVF chart →
